1990-2016年全球、区域和国家运动神经元病负担:2016年全球疾病负担研究的系统分析
该研究基于2016年全球疾病负担研究,采用贝叶斯荟萃回归模型和死因集成模型,估计1990至2016年195个国家和地区的运动神经元病发病率、患病率和伤残调整寿命年。2016年全球有330 918人患病,年龄标化患病率在高社会人口指数地区最高,患病率在1990至2016年间上升4.5%。
要点
- 2016年全球运动神经元病患病330 918人,死亡34 325人,产生926 090个伤残调整寿命年。
- 全球全年龄患病率为4.5/10万,年龄标化患病率在研究期间上升4.5%。
- 高社会人口指数地区年龄标化患病率最高,高收入北美为16.8/10万。
核心结论
- 运动神经元病患病率和发病率低,但致残严重且病死率高。
- 发病率存在地理异质性,无法用全球疾病负担研究中量化的任何危险因素解释,提示其他未测量危险因素可能起作用。
- 1990至2016年间运动神经元病负担显著增加。
研究设计与样本
- 研究纳入肌萎缩侧索硬化、脊髓性肌萎缩、遗传性痉挛性截瘫、原发性侧索硬化、进行性肌萎缩和假性延髓麻痹。
- 采用贝叶斯荟萃回归模型估计发病率、患病率和伤残调整寿命年。
- 分析14 165个地点-年的生命登记死因数据,使用2016年全球疾病负担死因集成模型。
- 检验2016年全球疾病负担中量化的84个危险因素与运动神经元病发病率或死亡的关联。
- 探索社会人口指数与运动神经元病年龄标化伤残调整寿命年的关系。
主要发现
- 2016年全球有330 918人(95%不确定性区间299 522-367 254)患有运动神经元病。
- 2016年运动神经元病导致926 090个伤残调整寿命年(881 566-961 758)和34 325例死亡(33 051-35 364)。
- 全球全年龄患病率为4.5/10万人(4.1-5.0),研究期间年龄标化患病率上升4.5%(3.4-5.7)。
- 全年龄发病率为0.78/10万人年(95%不确定性区间0.71-0.86)。
- 全球疾病负担中分析的任何危险因素均未显示与运动神经元病发病率相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 发病率存在地理异质性,无法用全球疾病负担研究中量化的任何危险因素解释,提示其他未测量危险因素可能起作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Understanding how prevalence, incidence, and mortality of motor neuron diseases change over time and by location is crucial for understanding the causes of these disorders and for health-care planning. Our aim was to produce estimates of incidence, prevalence, and disability-adjusted life-years (DALYs) for motor neuron diseases for 195 countries and territories from 1990 to 2016 as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016. METHODS: The motor neuron diseases included in this study were amyotrophic lateral sclerosis, spinal muscular atrophy, hereditary spastic paraplegia, primary lateral sclerosis, progressive muscular atrophy, and pseudobulbar palsy. Incidence, prevalence, and DALYs were estimated using a Bayesian meta-regression model. We analysed 14 165 site-years of vital registration cause of death data using the GBD 2016 cause of death ensemble model. The 84 risk factors quantified in GBD 2016 were tested for an association with incidence or death from motor neuron diseases. We also explored the relationship between Socio-demographic Index (SDI; a compound measure of income per capita, education, and fertility) and age-standardised DALYs of motor neuron diseases. FINDINGS: In 2016, globally, 330 918 (95% uncertainty interval [UI] 299 522-367 254) individuals had a motor neuron disease. Motor neuron diseases have caused 926 090 (881 566-961 758) DALYs and 34 325 (33 051-35 364) deaths in 2016. The worldwide all-age prevalence was 4·5 (4·1-5·0) per 100 000 people, with an increase in age-standardised prevalence of 4·5% (3·4-5·7) over the study period. The all-age incidence was 0·78 (95% UI 0·71-0·86) per 100 000 person-years. No risk factor analysed in GBD showed an association with motor neuron disease incidence. The largest age-standardised prevalence was in high SDI regions: high-income North America (16·8, 95% UI 15·8-16·9), Australasia (14·7, 13·5-16·1), and western Europe (12·9, 11·7-14·1). However, the prevalence and incidence were lower than expected based on SDI in high-income Asia Pacific. INTERPRETATION: Motor neuron diseases have low prevalence and incidence, but cause severe disability with a high fatality rate. Incidence of motor neuron diseases has geographical heterogeneity, which is not explained by any risk factors quantified in GBD, suggesting other unmeasured risk factors might have a role. Between 1990 and 2016, the burden of motor neuron diseases has increased substantially. The estimates presented here, as well as future estimates based on data from a greater number of countries, will be important in the planning of services for people with motor neuron diseases worldwide. FUNDING: Bill & Melinda Gates Foundation.
引用
- Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018. PMID: 30409709. doi:10.1016/S1474-4422(18)30404-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。